Patent details

EP3529248 Title: PHARMACEUTICAL COMPOUNDS

Basic Information

Publication number:
EP3529248
PCT Application Number:
GB2017053152
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177908134
PCT Publication Number:
WO2018073586
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOUNDS
French Title of Invention:
COMPOSÉS PHARMACEUTIQUES
German Title of Invention:
PHARMAZEUTISCHE VERBINDUNGEN
SPC Number:

Dates

Filing date:
18/10/2017
Grant date:
19/08/2020
EP Publication Date:
28/08/2019
PCT Publication Date:
26/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/08/2020
EP B1 Publication Date:
19/08/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/08/2020
 
 

Name:
CellCentric Ltd
Address:
Chesterford Research Park Little Chesterford, Cambridge, Cambridgeshire CB10 1XL, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
26/08/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
PEGG, Neil Anthony
Address:
United Kingdom (GB)

2

Name:
SHANNON, Jonathan
Address:
United Kingdom (GB)

3

Name:
PAOLETTA, Silvia
Address:
United Kingdom (GB)

4

Name:
SMYTH, Don
Address:
United Kingdom (GB)

5

Name:
ONIONS, Stuart Thomas
Address:
United Kingdom (GB)

6

Name:
HARBOTTLE, Gareth
Address:
United Kingdom (GB)

7

Name:
TADDEI, David Michel Adrien
Address:
United Kingdom (GB)

8

Name:
BROWN, Richard James
Address:
United Kingdom (GB)

Priority

Priority Number:
201617630
Priority Date:
18/10/2016
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/422; A61P 35/00; C07D 413/14; C07D 471/04;

Publication

European Patent Bulletin

Issue number:
202034
Publication date:
19/08/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/10/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
26/08/2020 Power Of Attorney 1
26/08/2020 Outgoing Correspondence 1